A double-blind clinical trial of kamalahar, an indigenous compound preparation, in acute viral hepatitis.

Simple item page
dc.contributor.authorDas, D Gen_US
dc.date.accessioned1993-10-01en_US
dc.date.accessioned2009-05-29T03:48:49Z
dc.date.available1993-10-01en_US
dc.date.available2009-05-29T03:48:49Z
dc.date.issued1993-10-01en_US
dc.description.abstractBACKGROUND: Kamalahar is an indigenous preparation reported to be beneficial in acute viral hepatitis. AIMS: To evaluate the efficacy of Kamalahain acute viral hepatitis in a double-blind, placebo-controlled study. METHODS: Fifty two patients with acute viral hepatitis were randomized to receive either Kamalahar 500 mg or a matched placebo three times a day for 15 days. Forty four patients (Kamalahar 20; placebo 24) completed the trial. RESULTS: Improvement in clinical signs was more marked with Kamalahar compared to placebo. The fall in serum bilirubin (p < 0.001), SGPT (p < 0.001) and serum alkaline phosphatase (p < 0.005) at day 15 was significantly greater with the drug. No significant side effects were observed. CONCLUSION: Kamalahar offers therapeutic promise in acute viral hepatitis.en_US
dc.description.affiliationClinical Pharmacology Department, Government General Hospital, Guntur.en_US
dc.identifier.citationDas DG. A double-blind clinical trial of kamalahar, an indigenous compound preparation, in acute viral hepatitis. Indian Journal of Gastroenterology. 1993 Oct; 12(4): 126-8en_US
dc.identifier.urihttps://imsear.searo.who.int/handle/123456789/65783
dc.language.isoengen_US
dc.source.urihttps://www.indianjgastro.comen_US
dc.subject.meshAcute Diseaseen_US
dc.subject.meshAdolescenten_US
dc.subject.meshAdulten_US
dc.subject.meshDouble-Blind Methoden_US
dc.subject.meshFemaleen_US
dc.subject.meshHepatitis, Viral, Human --drug therapyen_US
dc.subject.meshHumansen_US
dc.subject.meshMaleen_US
dc.subject.meshMedicine, Ayurvedicen_US
dc.subject.meshMiddle Ageden_US
dc.subject.meshPlant Extracts --therapeutic useen_US
dc.titleA double-blind clinical trial of kamalahar, an indigenous compound preparation, in acute viral hepatitis.en_US
dc.typeClinical Trialen_US
dc.typeJournal Articleen_US
dc.typeRandomized Controlled Trialen_US
Files
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.79 KB
Format:
Plain Text
Description:
Download
Collections
Indian Journal of Gastroenterology